About this Webinar
Cell and gene therapies (CGTs) are revolutionizing how diseases are treated by addressing conditions at the genetic or cellular level. With the potential to not just manage symptoms but cure or significantly alleviate certain conditions, CGTs don’t come without challenges. In this session, attendees will hear from Lisa Kallenbach, M.D., MPH and Jenny Jarboe, MBA as they explore the potential of CGTs to improve health outcomes, attract and retain talent and reshape employer-sponsored health plans. They’ll cover:
- The crucial role employers have in expanding access to CGTs and strategies to incorporate CGTs in your organization;
- The patient experience before and after treatment;
- Firsthand insights from Johnson & Johnson and its partner in navigating the evolving CGT landscape.